Skip to content

Innovative Neoadjuvant Therapies and Surgical Techniques in Rectal Cancer Organ Preservation

Organ preservation in rectal cancer is a rapidly evolving field within oncology, driven by the need to balance effective cancer treatment with the preservation of quality of life. Colorectal cancer ranks as the fourth most common cancer globally and is the third leading cause of cancer-related deaths. The treatment of rectal cancer presents unique challenges, including the risk of major resectional surgery, which often necessitates a permanent colostomy, significantly impacting patients' quality of life. Current treatment strategies are influenced by a variety of factors such as patient demographics, tumor characteristics, and regional medical guidelines. Multimodal therapies, including chemotherapy and radiotherapy, are commonly employed to shrink tumors and potentially allow for less invasive surgical interventions. However, the response to neoadjuvant chemoradiotherapy is unpredictable, and there is a notable absence of reliable biomarkers to guide personalized treatment strategies. Recent advancements in surgical techniques, such as transanal endoscopic microsurgery (TEM) and transanal minimally invasive surgery (TAMIS), have shown promise in preserving organ function and avoiding permanent colostomies, highlighting the need for further research into organ-preserving strategies.This Research Topic aims to explore and discuss potential strategies for organ preservation in patients with rectal cancer. The primary objective is to investigate novel neoadjuvant methods that can induce clinical responses, thereby reducing the need for invasive surgeries. Additionally, the research will focus on evaluating the effectiveness of contact radiotherapy and minimally invasive surgical techniques, as well as assessing long-term patient outcomes and quality of life. By addressing these areas, the research seeks to contribute to the development of personalized treatment approaches that prioritize both cancer eradication and the preservation of organ function.To gather further insights in the realm of organ preservation in rectal cancer, we welcome articles addressing, but not limited to, the following themes:- Innovative neoadjuvant therapies and their clinical outcomes- Advances in contact radiotherapy and its role in organ preservation- Long-term follow-up studies on patients who have undergone organ-preserving treatments- Quality of life assessments and patient-reported outcomes post-treatment- The role of advanced surgical techniques like TEM and TAMIS in preserving organ function- Exploration of predictive biomarkers for treatment response- Comparative studies of traditional versus organ-preserving treatment approachesPlease note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic. Topic editors: Matthew Fok, Arthur Sun Myint, Rachael Clifford, Hayley Fowler Source: https://www.frontiersin.org/research-topics/62731/innovative-neoadjuvant-therapies-and-surgical-techniques-in-rectal-cancer-organ-preservation

Open for submissionsHosted by Frontiers in Oncology
Contribute to this topic

Articles in this collection

No articles published in this topic yet.